NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

NHS England · awarded 16 April 2025 · delivered in East Midlands

£11.7m Award value £11,656,086

31 Suppliers Recorded as a small or medium-sized business

31 May 2027 Runs until from 1 Jun 2025

Who

Buyer	NHS England Runcorn, Cheshire
Suppliers	Accord-UK Ltd Amarox Limited Aspire Pharma Limited B. Braun Medical Limited Bowmed Ibisqus Limited Dr.Reddy's Laboratories (UK) Limited Drugsrus Ltd Farmak Pharmaceuticals Fresenius Kabi Limited Grindeks Kalceks UK Ltd JCSH Pharma Ltd Kent Pharma Ltd Luye Pharma Ltd Macleods Pharma UK Limited Martindale Pharma Medreich PLC Mercury Pharmaceuticals Limited Milpharm Ltd/aurobinbdo Primary Morningside Pharmaeuticals Mylan Neon Healthcare Ltd Novumgen Limited Panpharma UK Limited Pfizer Ltd Rosemont Pharmaceuticals Limited SVP Pharma Ltd Seacross Pharmaceuticals Ltd Teva UK Limited Wockhardt UK Limited ennogen healthcare ltd hameln pharma ltd
Category	goods
Classification	Pharmaceutical products CPV 33600000
Notice published	8 May 2025

What it is for

Project title: NHS National Framework for the supply of Generics Housekeeping Products & Oral Products, commencing 1 June 2025 Offer reference number: CM/PHG/24/5720 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5720/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months) CM/PHG/24/5720/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Read the original award notice on Contracts Finder →

Other contracts from this buyer

1270 awards on file, worth £50.2bn.

Awarded	What for	Buyer	Supplier	Value
4 Mar 2026	New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland	NHS England	Willmott Dixon Construction Limited +9	£37.0bn
24 Mar 2025	NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands	NHS England	CSL Behring UK Ltd +71	£1.2bn
1 Jul 2025	NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025	NHS England	Biogen +20	£986.3m
19 Dec 2024	NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland	NHS England	CSL Behring UK Ltd +5	£905.2m
31 May 2024	NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands	NHS England	Pfizer Ltd +8	£765.0m

Everything NHS England has awarded →

Other contracts won by this supplier

2 awards on file, worth £1.3bn.

Awarded	What for	Buyer	Supplier	Value
24 Mar 2025	NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands	NHS England	CSL Behring UK Ltd +71	£1.2bn
16 Apr 2025	NHS National Framework - Generics Housekeeping/Supply Chain Resilience ProductsEast Midlands	NHS England	Drugsrus Ltd +30	£11.7m

Everything Drugsrus Ltd has won →